Cor Vasa 2016, 58(4):e426-e430 | DOI: 10.1016/j.crvasa.2015.08.008
Current look on postural tachycardia syndrome
- I. interní klinika, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc, Olomouc, Česká republika
Introduction: Postural tachycardia syndrome (POTS) is one of the common causes of orthostatic intolerance. It is a pathophysiologically heterogeneous disorder characterized by orthostatic intolerance and an increase of heart rate by 30 bpm in the first 10 min after standing up or during head-up tilt test (HUTT) without orthostatic hypotension.
Clinical features: Symptoms accompanying this syndrome are those due to cerebral hypoperfusion and due to sympathetic hyperactivity and consist of orthostatic, nonorthostatic and diffuse associated symptoms.
Classification: For this heterogeneous group of disorders, many different classifications have been proposed. The most practical classification consistent with current medical evidence and in terms of clinical usefulness seems to be the classification based on POTS phenotypes: partial dysautonomic (neuropathic) form of POTS, hyperadrenergic POTS, POTS associated with poor conditioning, and POTS and volume dysregulation.
Diagnosis and examinations: Systematic and practical approach is essential to properly manage POTS. The patient should undergo a thorough cardiac and neurologic examination including EKG Holter monitoring and ambulant blood pressure monitoring. Screening HUTT has been shown to be helpful in the evaluation of patients with syncope of unknown cause, including POTS.
Differential diagnosis: The clinical manifestation of POTS can be similar to pheochromocytoma, vasovagal syncope, inappropriate sinus tachycardia and other supraventricular tachyarrhythmias. In all patients with signs of autonomic neuropathy, an underlying cause of neurological deficit, deficit should be diagnosed, compensated and ruled out as a primary cause.
Treatment: The treatment of POTS is mainly non-pharmacological. All patients need to be educated and need to understand POTS. Structured exercise program can have huge benefits. Pharmacological treatment is supportive and aims for volume expansion, sympatholysis, vasoconstrictor and increasing vagal tone.
Conclusion: Although POTS was described in the 1990s, many aspects of this multisystemic orthostatic disorder still remain unclear. This syndrome significantly affects the patient's quality of life. It is necessary to broaden the general knowledge of first-line doctors in private and specialized practices to better manage the patients suffering from POTS and to refer them to specialized centers with available comprehensive diagnostic options and care.
Keywords: Diagnostics; Head-up tilt test; Management; Orthostatic intolerance; Pathophysiology; POTS; Syncope; Treatment
Received: May 26, 2015; Revised: August 20, 2015; Accepted: August 25, 2015; Published: August 1, 2016 Show citation
References
- E.E. Benarroch, Postural tachycardia syndrome: a heterogeneous and multifactorial disorder, Mayo Clinic Proceedings 87 (2012) 1214-1225.
Go to original source...
Go to PubMed...
- S.R. Raj, The postural tachycardia syndrome (POTS): pathophysiology, diagnosis & management, Indian Pacing and Electrophysiology Journal 6 (2006) 84-99.
Go to PubMed...
- P.A. Low, T.L. Opfer-Gehrking, S.C. Textor, Postural tachycardia syndrome (POTS), Neurology 45 (4 Suppl. 5) (1995) S19-S25.
- P. Sandroni, T.L. Opfer-Gehrking, B.R. McPhee, P.A. Low, Postural tachycardia syndrome: clinical features and follow-up study, Mayo Clinic Proceedings 74 (1999) 1106-1110.
Go to original source...
Go to PubMed...
- M.J. Thieben, P. Sandroni, D.M. Sletten, Postural orthostatic tachycardia syndrome: the Mayo Clinic experience, Mayo Clinic Proceedings 82 (2007) 308-313.
Go to original source...
Go to PubMed...
- R. Schondorf, J. Benoit, T. Wein, D. Phaneuf, Orthostatic intolerance in the chronic fatigue syndrome, Journal of the Autonomic Nervous System 75 (1999) 192-201.
Go to original source...
Go to PubMed...
- G. Jacob, F. Costa, J.R. Shannon, The neuropathic postural tachycardia syndrome, New England Journal of Medicine 343 (2000) 1008-1014.
Go to original source...
Go to PubMed...
- B.P. Grubb, Y. Kanjwal, D.J. Kosinski, The postural tachycardia syndrome: a concise guide to diagnosis and management, Journal of Cardiovascular Electrophysiology 17 (2006) 108-112.
Go to original source...
- B.P. Grubb, P. Row, H. Calkins, Postural tachycardia, orthostatic intolerance and the chronic fatigue syndrome, in: B.P. Grubb, B. Olshansky (Eds.), Syncope: Mechanisms and Management, 2nd ed., Malden, MA: Blackwell/Future Press; 2005, p. 225-244.
Go to original source...
- S. Vernino, P.A. Low, R.D. Fealy, et al., Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies, New England Journal of Medicine 343 (2000) 847-855.
Go to original source...
Go to PubMed...
- S. Vincent, D. Robertson, Hyperadrenergic postural tachycardia syndrome, in: D. Robertson (Ed.), Primer on the Autonomic Nervous System, San Diego, CA: Elsevier Academic Press; 2004, p. 344-345.
Go to original source...
- V.C. Nwazue, S.R. Raj, Confounders of vasovagal syncope: postural tachycardia syndrome, Cardiology Clinics 31 (2013) 101-109.
Go to original source...
Go to PubMed...
- S. Masuki, J.H. Eisenach, C.P. Johnson, et al., Excessive heart rate response to orthostatic stress in postural tachycardia syndrome is not caused by anxiety, Journal of Applied Physiology 102 (2007) 896-903.
Go to original source...
Go to PubMed...
- D.H. Streeten, D. Thomas, D.S. Bell, The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome, American Journal of the Medical Sciences 320 (2000) 1-8.
Go to original source...
Go to PubMed...
- J.M. Stewart, A.J. Ocon, D. Clarke, et al., Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome, Hypertension 53 (2009) 767-774.
Go to original source...
Go to PubMed...
- P.A. Low, POTS, in: P.A. Low, E.E. Benarroch (Eds.), Clinical Autonomic Disorders, 3rd ed., Philadelphia, PA: Lippincott; 2008, p. 515-533.
- P.A. Low, T.L. Opfer-Gehrking, S.C. Textor, et al., Postural tachycardia syndrome (POTS), Neurology 45 (1995) S19-S25.
- F.M. Fouad, L. Tadena Thome, E.L. Bravo, R.C. Tarazi, Idiopathic hypovolemia, Annals of Internal Medicine 104 (1986) 298-303.
Go to original source...
Go to PubMed...
- R.D. Hoeldtke, G.E. Dworkin, S.R. Gaspar, B.C. Israel, Sympathotonic orthostatic hypotension: a report of four cases, Neurology 39 (1989) 34-40.
Go to original source...
Go to PubMed...
- M. Thieben, P. Sandroni, D. Sletten, et al., Postural orthostatic tachycardia syndrome - Mayo Clinic experience, Mayo Clinic Proceedings 82 (2007) 308-313.
Go to original source...
Go to PubMed...
- F. Abi-Samra, J.D. Maloney, F.M. Fouad-Tarazi, L.W. Castle, The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin, Pacing and Clinical Electrophysiology 11 (1988) 1202-1214.
Go to original source...
Go to PubMed...
- Q. Fu, T.B. Vangundy, S. Shibata, et al., Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome, Hypertension 58 (2011) 167-175.
Go to original source...
Go to PubMed...
- Q. Fu, T.B. Vangundy, M.M. Galbreath, et al., Cardiac origins of the postural orthostatic tachycardia syndrome, Journal of the American College of Cardiology 55 (2010) 2858-2868.
Go to original source...
Go to PubMed...
- G. Jacob, J.R. Shannon, B. Black, et al., Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia, Circulation 96 (1997) 575-580.
Go to original source...
Go to PubMed...
- S.R. Raj, I. Biaggioni, P.C. Yamhure, et al. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation 111 (2005) 1574-1582.
Go to original source...
Go to PubMed...
- S.T. Coffin, B.K. Black, I. Biaggioni, et al., Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome, Heart Rhythm 9 (2012) 1484-1490.
Go to original source...
Go to PubMed...
- S.R. Raj, B.K. Black, I. Biaggioni, et al. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation 120 (2009) 725-734.
Go to original source...
Go to PubMed...
- B.P. Grubb, B. Karas, D. Kosinski, K. Boehm, Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope, Journal of Interventional Cardiac Electrophysiology 3 (1999) 139-143.
Go to original source...
Go to PubMed...
- S.R. Raj, B.K. Black, I. Biaggioni, et al., Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome, Circulation 111 (2005) 2734-2740.
Go to original source...
Go to PubMed...
- W. Singer, T.L. Opfer-Gehrking, K.K. Nickander, et al., Acetylcholinesterase inhibition in patients with orthostatic intolerance, Journal of Clinical Neurophysiology 23 (2006) 476-481.
Go to original source...
Go to PubMed...
- K. Kanjwal, B. Karabin, M. Sheikh, et al., Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience, Pacing and Clinical Electrophysiology 34 (2011) 750-755.
Go to original source...
Go to PubMed...